🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
The purpose of this study is to investigate the efficacy and safety of long...
Status
Completed
Location
Kameda Medical Center
Start Date
2018-02-18
Trial ID
NCT03416374
Treatments Being Tested
This study will test how effective the drug, Carfilzomib, reduces progressi...
Status
Completed
Location
Birmingham VA Medical Center
Start Date
2014-04
Trial ID
NCT02047253
Treatments Being Tested
Since 2009, the Department of Clinical Haematology at Limoges University Ho...
Status
Completed
Location
Limoges Hospital
Start Date
2021-09-15
Trial ID
NCT05041933
Treatments Being Tested
The primary objective of this study was to compare progression-free surviva...
Status
Completed
Location
Providence St. Joseph Medical Center
Start Date
2012-06-20
Trial ID
NCT01568866
Treatments Being Tested
This is a study of pembrolizumab (MK-3475) in combination with lenalidomide...
Status
Terminated
Location
Multiple Locations
Start Date
2014-02-14
Trial ID
NCT02036502
Treatments Being Tested
The goal of this clinical research study is to find the highest tolerable d...
Status
Completed
Location
University of Texas MD Anderson Cancer Center
Start Date
2014-06-17
Trial ID
NCT01926665
Treatments Being Tested
This is a non-interventional observational study aiming to evaluate the qua...
Status
Recruiting
Location
Seoul St. Mary Hospital
Start Date
2025-07-14
Trial ID
NCT07051850
Double-blind study will compare the efficacy and assess safety of selinexor...
Status
Withdrawn
Location
James R. Berenson MD, Inc
Start Date
2015-12
Trial ID
NCT02628704
Treatments Being Tested
Multiple myeloma (MM) is a cancer of the blood's plasma cells. The cancer i...
Status
Recruiting
Location
City of Hope National Medical Center /ID# 273132
Start Date
2025-06-30
Trial ID
NCT06892522
This is a Phase IB/II trial that will investigate the safety, tolerability ...
Status
Recruiting
Location
Houston Methodist Neal Cancer Center
Start Date
2024-07-29
Trial ID
NCT06536413